Faculty Information - Tamaki Sasaki

Present specialized field

BooK

Journal

Presentation

（Last updated : 2024-04-23 14:03:23）

Tamaki Sasaki
Department Kawasaki Medical School Kawasaki Medical School, Department of Nephrology and Hypertension,

Position Professor

■ Present specialized field

Nephrology, Others

■ BooK

2017/01

Clearance Gap: Does It Really Matter for the Evaluation of Vascular Access Function?, Scientific Aspects of Dialysis Therapy (in Contributions to Nephrology)

■ Journal

1.	2023/12/19	IL-1β may be an indicator of peritoneal deterioration after healing of peritoneal dialysis-associated peritonitis.
2.	2023/10/01	Insights into the regulation of glomerular filtration rate by the Keap1-Nrf2 pathway
3.	2023/09	Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis.
4.	2023/06	The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study
5.	2022/03/23	A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis
6.	2021/11	Dipeptidyl peptidase-4 inhibitor linagliptin reduces urinary albumin excretion through the protection of glomerular endothelial function
7.	2021/08/27	Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation
8.	2021/08	A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis.
9.	2021/06	Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging
10.	2021/05/11	Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.
11.	2020/11/01	Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.
12.	2020/05/01	Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition.
13.	2020/05	Impact of heavy rains of 2018 in western Japan: disaster-induced health outcomes among the population of Innoshima Island
14.	2019/11	Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function.
15.	2019/07	Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.
16.	2019/01	5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
17.	2018/01	Proteinuria in neuronal intranuclear inclusion disease
18.	2017/08	Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice.
19.	2017/06	Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model.
20.	2017/06	Restricted nutrition-induced low birth weight, low number of nephrons and glomerular mesangium injury in Japanese quail.
21.	2016/10	Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
22.	2016/01	Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.
23.	2015/12	Severe hyperkalemia following ileostomy not colostomy in a patient undergoing chronic hemodialysis
24.	2015/09	Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice.
25.	2015/09	Relationship between vascular function indexes, renal arteriolosclerosis, and renal clinical outcomes in chronic kidney disease.
26.	2015/08	Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice.
27.	2015/05	Combination Irbesartan/Amlodipine versus Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin-Induced Diabetic Nephropathy
28.	2014/12	Nuclear Factor Erythroid 2-Related Factor 2 is Activated by Rosuvastatin via p21cip1 Upregulation in Endothelial Cells
29.	2014/02	Angiotensin II Regulates Islet Microcirculation and Insulin Secretion in Mice.
30.	2014	Hypertension promotes islet morphological changes with vascular injury on pre-diabetic status in SHRsp rats.
31.	2013/06	Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.
32.	2013/04	Erythropoietin-producing tubercle granuloma in a hemodialysis patient.
33.	2013/04	Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status.
34.	2013/03	Angiostatin production increases in response to decreased nitric oxide in aging rat kidney.
35.	2012/12	Establishment of a blood purification system for renal failure rats using small-size dialyzer membranes.
36.	2012/12	Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).
37.	2012/08	Tacrolimus Induces Glomerular Injury via Endothelial Dysfunction Caused by Reactive Oxygen Species and Inflammatory Change.
38.	2012/06	Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice.
39.	2012/03	Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
40.	2011/08	Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan.
41.	2011/04	Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals.
42.	2011/02	Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney.
43.	2011	Comparison of Combination Therapy of Olmesartan plus Azelnidipine or Hydrochlorothiazide on Renal and Vascular Damage in SHR/NDmcr-cp Rats.
44.	2010/11	Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera
45.	2010/09	Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.
46.	2010/07	Clear Correlation of Tetrahydrobiopterin with Nitric Oxide Bioavailability in Continuous Ambulatory Peritoneal Dialysis
47.	2010/02	In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats.
48.	2010/02	Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
49.	2009/12	Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.
50.	2009/10	Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.
51.	2009/09	Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney
52.	2009/06	Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
53.	2009/05	High dietary protein intake induces endothelial dysfunction in uninephrectomized rats
54.	2009/01	Direct Measurement of Nitric Oxide Concentration in CAPD Dialysate
55.	2008/12	Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy
56.	2008/04	Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
57.	2008/04	Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
58.	2008	Abdominal pain as the initial presentation of Takayasu arteritis.
59.	2008	Co-occurrence of poststreptococcal reactive arthritis and acute glomerulonephritis.
60.	2008	Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study.
61.	2007/10	Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
62.	2007/10	Pioglitazone ameliorates endothelial dysfunction in obese rats with nephropathy.
63.	2007/02	Amelioration of progressive renal injury by genetic manipulation of Klotho gene.
64.	2007/02	Isohumulones Derived from Hops Ameliorate Renal Injury via an Anti-Oxidative Effect in Dahl Salt-Sensitive Rats.
65.	2006/02	A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure
66.	2006	Implication of Peritubular Capillary Loss and Altered Expression of Vascular Endothelial Growth Factor in IgA Nephropathy.
67.	2005/06	A case of Vogt-Koyanagi-Harada disease that developed relapsing polychondritis.
68.	2005/06	NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
69.	2003/12	Immunization with ACE (angiotensin converting enzyme) develops diabetic changes in the kidney and retina in diabetogenic rats.
70.	2003/06	A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.
71.	2001/11	Membranous nephropathy associated with hepatitis C virus infection.
72.	2001/06	hOGG1 polymorphism correlates with progression of IgA Nephropathy
73.	2001/04	Transdominant negative FGF receptors inhibit proliferation of cultured glomerular mesangial cells.
74.	2000	hOGG1 polymorphism correlates with progression of IgA Nephropathy (IgA GN)
75.	2000	hOGG1 polymorphism is correlated with pathogenesis of Diabetic Nephropathy (DN)
76.	2000	Oxidative stress induced peritoneal injury
77.	2000	Role of mitochondrial damage due to oxidative stress in Diabetic Nephropathy (DN)
78.	2000	Role of mitochondrial oxidative stress in the development of glomerulosclerosis
79.	1999/11	Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis.
80.	1999/01	Cytokines and podocyte injury: the mechanism of fibroblast growth factor 2-induced podocyte injury.
81.	1999	Podocytes mitochondria and their mit DNA mutation in mitochondrial disease
82.	1997/01	Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy
83.	1997	A kinetic study of glomerular epithelial cells associated with segmental glomerular sclerotic lesions with adhesion in spontaneous diabetic WBN/Kob rats.
84.	1997	Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy
85.	1997	Expression of tenascin in mesangial injury in experimental glomerulonephritis.
86.	1997	Kinetic study of glomerular epithelial cells associated with segmental glomerular sclerosis lesions with adhesion in spontaneovs diabetic WBN/Kob rats
87.	1996	Detection of osteopontin mRNA in epithelial cells of Bowman's capsule as revealed by in situ hybridization.
88.	1994	An Ultrastructural Study of Rat Glomerular Epithelial Cells in Culture
89.	1993	A kinetic study of the glomerular cells of developing and immature rat kidneys using an anti-bromodeoxyuridine monoclonal antibody
90.	1992	Observation of foot processes of podocytes
91.	1992	The injuries of podocytes promote irreversible glomerular sclerosis
92.	1991	Effect of N, N'-diacetylbenzidine on glomerular basement membrane formation in newborn rat kidney
93.	1991	Kinetic study of podocytes in glomerular sclerosis
94.	1990	Ultrastructural observation of the role of Bowman's epithelium in segmental glomerular sclerosis
95.	1989	A study of bone metabolism of renal osteodystrophy
Display 5 items
Display all(95)

■ Presentation

1.	2023/11/02	Elucidation of the Molecular Mechanism of Albuminuria Improvement by Nonsteroidal Mineralocorticoid Receptor (MR) Antagonists Focusing on Podocyte Calcium (Ca2+) Dynamics （ポスター掲示，一般）
2.	2022/02/20	Effect of sodium-glucose cotransporter 2 inhibitor, canagliflozin, on glomerular hyperfiltration and oxidative stressin mice with type 2 diabetes. （口頭，一般）
3.	2021/02/28	Evaluation of glomerular hemodynamic changes by SGLT2 inhibitor and ARB in type 2 diabetic rats using in vivo imaging （口頭，一般）
4.	2020/10/19	Effect of Zinc Deficiency on CKD Progression and Effect Modification by Hypoalbuminemia. （一般）
5.	2020/10/19	eNOS/NO Signaling Attenuates Progression of Age-Related Kidney Diseases via Suppression of Inflammasome. （一般）
6.	2020/10/02	EVALUATION OF THE MECHANISM OF GLOMERULAR ARTERIOLE CHANGES BY SGLT2 INHIBITION IN TYPE 2 DIABETIC RATS （ポスター掲示，一般）
7.	2020/10/02	Inflammasome Activation Plays a Key Role on the Progression of Peritoneal Fibrosis in Mice （ポスター掲示，一般）
8.	2020/10/02	THE EFFECTS OF SGLT2 INHIBITORS ON GLOMERULAR HYPERFILTRATION AND OXIDATIVE STRESS IN MICE WITH DIABETIC KIDNEY DISEASE （ポスター掲示，一般）
9.	2020/06/07	Effects of sodium–glucose cotransporter 2 inhibitor, canagliflozin on glomerular hyperfiltration and oxidative stress in mice with type 2 diabetes （口頭，一般）
10.	2020/06/07	EVALUATION OF GLOMERULAR HEMODYNAMIC CHANGES BY SGLT2 INHIBITION IN TYPE 2 DIABETIC RATS USING IN VIVO IMAGING TECHNIQUES （口頭，一般）
11.	2020/06/07	KEAP1/NRF2 PATHWAY REGULATES GFR BY INCREASING THE GLOMERULAR EFFECTIVE AREA WITHOUT AFFECTING THE AFFERENT/EFFERENT ARTERIOLE RATIO （口頭）
12.	2020/02/15	Zinc deficiency is a risk factor for chronic kidney disease progression （口頭，一般）
13.	2019/11/09	Implication of Inflammasome Activation in the Progression of Peritoneal Fibrosis in Mice （ポスター掲示，一般）
14.	2019/11/08	Clarification of the Mechanism of Acute GFR Change by SGLT2 Inhibition with In Vivo Imaging Technique （ポスター掲示，一般）
15.	2019/09/07	A Case of rapid decline of residual renal function after initiation of initiation of peritoneal dialysis. （ポスター掲示，一般）
16.	2019/09/05	Inframmasome activation plays a key role in chronic inflammation and development of peri-toneal fibrosis （ポスター掲示，一般）
17.	2019/06/13	Implication of inflammasome activation in the development of peritoneal fibrosis. （ポスター掲示，一般）
18.	2019/06/13	Investigation of the suppressive effects of an SGLT2 inhibitor on glomerular hyperfiltration and oxidative stress in mice with diabetic kidney disease. （ポスター掲示，一般）
19.	2019/04/12	Effect of uremic toxin-indoxcyl sulfate on intestinal defensin expression in renal failure mice. （ポスター掲示，一般）
20.	2019/04/12	Evaluation of the diabetic glomerular hemodynamics by SGLT2 inhibitor empagliflozin using in vivo imaging. （ポスター掲示，一般）
21.	2018/10/25	Endothelial Dysfunction Exacerbates Renal Tubular Cell Injury Through Inflammasome Activation in a Hypertensive Mouse Model （ポスター掲示，一般）
22.	2018/10/25	Nrf2 Activator, RTAdh404, Attenuates Tubular Injury via Eliminating Mitochondrial ROS in Proteinuria Induced Renal Failure Mice （ポスター掲示，一般）
23.	2018/10/25	Uremic Toxin Decreases Intestinal Defense Peptides and Barrier Functions in Chronic Renal Failure Mice （ポスター掲示，一般）
24.	2018/06/23	Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging. （口頭，一般）
25.	2018/05/25	EVALUATION OF THE GLOMERULAR HEMODYNAMICS BY THE SGLT2 INHIBITOR EMPAGLIFLOZIN USING IN VIVO IMAGING （ポスター掲示，一般）
26.	2018/05/25	NRF2 ACTIVATOR, RTADH404, ATTENUATES RENAL TUBULAR INJURY VIA MITOCHONDRIAL PROTECTION IN NEPHROTIC MODEL MICE. （ポスター掲示，一般）
27.	2018/02/22	5-aminolevulinic acid exerts renoprotective effect via Nrf2 activation in rhabdomyolysis-induced acute kidney injury . （ポスター掲示，一般）
28.	2018/02/22	A case of copper deficiency-induced pancytopenia with maintenance hemodialysis outpatient treated with polaprezinc . （ポスター掲示，一般）
29.	2018/02/22	Diagnosis of a case of anti-neutrophil cytoplasmic antibody associated Glomerulonephritis during a school health examination. （ポスター掲示，一般）
30.	2018/02/22	DPP4 inhibitor linagliptin ameliorates diabetic kidneydisease through the protection of glomerular endothelial function in mice. （ポスター掲示，一般）
31.	2018/02/22	Effect of single pill-based combination therapy on variability of home blood pressure in hypertensive outpatients. （ポスター掲示，一般）
32.	2018/02/22	eNOS -NO signaling attenuates renal fibrosis via suppression of catenin signaling. （ポスター掲示，一般）
33.	2018/02/22	Evaluation of the glomerular hemodynamics alterations by SGLT2 inhibitor Empagliflozin using in vivo imaging. （ポスター掲示，一般）
34.	2018/02/22	Membranous nephropathy diagnosed in the early stages of pregnancy :A case report. （ポスター掲示，一般）
35.	2018/02/22	Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins2Akita diabetic mice. （ポスター掲示，一般）
36.	2018/02/22	RTAdh404 attenuates renal inflammation and fibrosis via mitochondrial protection in ICGN mice. （ポスター掲示，一般）
37.	2018/02/22	The association of microbiota alteration and intestinal barrier function in chronic renal failure mice. （ポスター掲示，一般）
38.	2018/02/22	The eNOS/NO signaring attenuates glomerular injury in diabetic mice via suppression of inflammasome activation. （ポスター掲示，一般）
39.	2018/02/10	Evaluation of the glomerular hemodynamics alterations by SGLT2 inhibitor Empagliflozin in diabetic mice using in vivo imaging. （ポスター掲示，一般）
40.	2017/11/03	Deficient of Endothelial Function Exacerbates NLRP3-Inflammasome Activation in Podocyte of Diabetic Nephropathy （ポスター掲示，一般）
41.	2017/11/02	Evaluation of the Reno-Protective Effects of Empagliflozin in Diabetic Nephropathy Using In Vivo Imaging （ポスター掲示，一般）
42.	2017/09/15	DPP4 inhibitor reduces urinary albumin excretion through the protection of glomerular endothelial function （口頭，一般）
43.	2017/09/15	Evaluation of the effect of empagliflozin on improving hyperfiltration in diabetic nephropathy （口頭，一般）
44.	2017/06/05	ENOS/NO Signaling Attenuates Glomerular Injury in Diabetic Mice via Suppression of Inflammasome Activation. （ポスター掲示，一般）
45.	2016/11/17	Nrf2 Dependent Inflmmasome Activation Contributes to Maintain M1 Macrophage but Not M2 Infiltration in Kidney Disease Model . （ポスター掲示，一般）
46.	2016/11/17	The DPP-4 Inhibitor Linagliptin Reduces Albuminuria Independently of Blood Glucose Levels （ポスター掲示，一般）
47.	2016/11/16	eNOS-NO Pathway Attenuates Chronic Inflammation via Nitric Oxide in Hypertensive Kidney Disease. （ポスター掲示，一般）
48.	2016/09/28	Effect of Single Pill-Based Combination Therapy of Olmesartan and Azelnidipine on Variability of Home Blood Pressure in Hypertensive Outpatients. （ポスター掲示，一般）
49.	2016/09/27	Feasibility of Fluorescence Energy Transfer System for Imaging the Renoprotective Effects of Aliskiren in Diabetic Mice. （ポスター掲示，一般）
50.	2016/09/26	Hypertension Promotes Islet Morphological Changes with Vascular Injury on Prediabetic Status in SHR-SP Rats. （ポスター掲示，一般）
51.	2016/09/26	Possible Implication of Xanthine Oxidase Activation on the Pathogenesis Diabetic Nephropathy. （ポスター掲示，一般）
52.	2016/09/19	Renoprotective Effect of 5-Aminolevulinic Acid in Rhabdomyolysis-Induced Acute Kidney Injury （口頭，一般）
53.	2016/09/18	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （ポスター掲示，一般）
54.	2016/09/07	Clearance Gap: a new index for detection of vascular access dysfunction （ポスター掲示，一般）
55.	2016/05/31	Feasibility of Fluorescence Energy Transfer System for Imaging the Renoprotective Effects of Aliskiren in Diabetic Mice. （ポスター掲示）
56.	2016/02/27	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （口頭，一般）
57.	2015/11/07	5-Aminolevulinic Acid Attenuates Rhabdomyolysis-Induced Acute Kidney Injury in Mice . （ポスター掲示，一般）
58.	2015/11/06	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora in Chronic Renal Failure Mice. （ポスター掲示，一般）
59.	2015/11/05	Possible Implication of Xanthine Oxidase Activation on the Pathogenesis Diabetic Nephropathy. （ポスター掲示，一般）
60.	2015/09/28	Excess Aldosterone is a Critical Danger Signal for Inflammasome Activation in the Development of Renal Fibrosis in Mice. （ポスター掲示，一般）
61.	2015/09/25	Possible implication of xanthine oxidase activation on the pathogenesis diabetic nephropathy. （ポスター掲示，一般）
62.	2015/09/25	Visualization of in vivo renin activity and its application to study the pathogenetic mechanisms of diabetic nephropathy （ポスター掲示，一般）
63.	2015/03/16	Low-Dose Colchicine Treatment Attenuates Renal Fibrosis in Mice Unilateral Ureteral Obstruction. （ポスター掲示，一般）
64.	2015/02/28	Protective role of klotho protein on peritoneal membrane via suppression of wnt/B-catenin signaling in mice. （口頭，一般）
65.	2014/11/15	Klotho Overexpression Attenuates Peritoneal Fibrosis via Suppression of Wnt/B-Catenin Signaling Pathway in Mice （口頭，一般）
66.	2014/11/14	Enhancement of Wnt/B-Catenin Signaling Promotes Renal Fibrosis by Inducing Cell Cycle Arrest at the G2/M Phase in Tubular Epithelial Cells （ポスター掲示，一般）
67.	2014/10/17	Development of a Novel In Vivo-Imaging Technique to Detect Renin-Activity in an Attempt to Elucidate Reno-Protective Effects of Calcium-Channel Blocker （ポスター掲示，一般）
68.	2014/10/17	Molecular Mechanisms of Aldosterone-Induced Renal Interstitial Fibrosis and Ameliorative Effects of Mineralocorticoid Receptor Antagonist （口頭，一般）
69.	2014/06/01	Activation of eNOS Signaling Attenuates Renal Fibrosis in Mice by The Increase of Beta Catenin Degradation. （ポスター掲示，一般）
70.	2014/06/01	Rosuvastatin Reduces Albuminuria in Akita Diabetic mice by p21Cip1 up-regulation Through Nuclear Factor Erythroid 2-Like Factor2 Activation. （ポスター掲示，一般）
71.	2014/06/01	The Effect of Azelnizipine on Tissue/Plasma Renin Activity in mice with Diabetic Nephropathy. （ポスター掲示，一般）
72.	2014/05/15	Benidipine Attenuates Albuminuria Through Amelioration of Enos Uncoupling in Hypertensive Kidney Disease Model. （ポスター掲示，一般）
73.	2014/05/15	Implication of Inflammasome Activation in The Development of Renal Interstitial Inflammation and Fibrosis Induced by Aldosterone. （口頭，一般）
74.	2014/04/14	Nuclear factor erythroid 2-like factor 2 activation by rosuvastatin reduces albuminuria in Akita diabetic mice （ポスター掲示，一般）
75.	2014/02/22	Aldosterone induces renal tubulointerstitial inflammation and fibrosis via activation of inflammasome in infltrating macrophages. （ポスター掲示，一般）
76.	2013/11/09	Comparison of Combination Therapy with Irbesartan/Amlodipine and Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin-Induced Diabetic Nephropathy. （ポスター掲示，一般）
77.	2013/11/09	Rosuvastatin Activates Transcription Factor Nrf2 through p21cip1 Expression and Prevents Albuminuria through Preservation of Glomerular Endothelial Integrity in AKITA Diabetic Mice. （口頭，一般）
78.	2013/11/07	Implication of Inflammasome Activation via Mitochondrial Reactive Oxygen Species in the Development of Renal Interstitial Fibrosis Induced by Aldosterone. （ポスター掲示，一般）
79.	2013/11/07	T Type Ca-Channel Blocker Exerts Anti-Albuminuic Effect through Amelioration of eNOS Uncoupling in Hypertensive Kidney Disease Model. （ポスター掲示，一般）
80.	2013/10/26	Molecular Mechanism of Mineralocorticoid Receptor Antagonist on Suppressive Effects of Inflammasome Activation by Aldosterone. （ポスター掲示，一般）
81.	2013/10/24	Comparison of Combination Therapy with Irbesartan/Amlodipine and Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin Induced Diabetic Nephropathy. （ポスター掲示，一般）
82.	2013/10/24	Investigation for the Mechanisms of Anti-albuminuic Effects of T Type Ca-channel Blocker through Amelioration of eNOS Uncoupling. （口頭，一般）
83.	2013/10/24	Islet Microangiopathy in Hypertensive Rats and the Protective Effects of ARB on the Islet Morphology. （口頭，一般）
84.	2013/06/02	Implications of Inflammasome-Activation in Macrophage on the Development of Renal Interstitial Inflammation and Fibrosis in Mice. （ポスター掲示，一般）
85.	2013/06/01	Development of Novel Technique to Visualize in vivo Renin Activity and Analysis of Reno-Protective Actions of Renin Inhibitor in Diabetic Nephropathy. （ポスター掲示，一般）
86.	2013/06/01	Klotho Protein Ameliorates Peritoneal Fibrosis Though The Regulation of Wnt/B-Catenin Signaling. （ポスター掲示，一般）
87.	2013/06/01	Rosuvastatin Maintain Glomerular Endothelial Surface layer Through Nrf2 Activation in Mouse Diabetic Nephropathy. （ポスター掲示，一般）
88.	2013/04/28	Aldosterone induces renal interstitial inflammation and fibrosis by activation of inflammasome via mitochondrial reactive oxygen species in macrophage. （ポスター掲示，一般）
89.	2013/04/21	Implication of inflammasome in the development of renal interstitial fibrosis induced by aldsoterone （ポスター掲示，一般）
90.	2012/11/06	Spironolactone Suppresses the Inflammasome in Aldosterone Induced Renal Dysfunction via Blood Pressure Independent Pathway. （ポスター掲示，一般）
91.	2012/11/03	Rosuvastatin Activates Transcription Factor Nrf2 and Protects Prevents Albuminuria through Preservation of the Glomerular Endothelial Integrity in Akita Diabetic Mice. （ポスター掲示，一般）
92.	2012/11/02	Erythropoietin Activates NAD(P)H Oxidase via Erythropoietin Receptor and Beta Common Receptor on Vascular Endothelial Cells. （ポスター掲示，一般）
93.	2012/11/02	Klotho Attenuates Inflammation of Adipose Tissue and Development of Insulin Resistance in High-Fat Induced Obese Mice. （ポスター掲示，一般）
94.	2012/11/02	Overexpression of the Klotho Protein Attenuates Peritoneal Fibrosis by Suppressing Wnt-Signaling. （ポスター掲示，一般）
95.	2012/11/02	Stimulation of Soluble Guanylate Cyclase Attenuates Epithelial-Mesenchymal Transition of the Peritoneal Membrane and Prevent the Development of Peritoneal Fibrosis. （口頭，一般）
96.	2012/11/01	Development of a Novel Technique to Visualize In Vivo Renin Activity and Analysis of the Renoprotective Actions of a Renin Inhibitor. （ポスター掲示，一般）
97.	2012/07/20	eNOS-sGC pathway suppresses renal fibrosis via interruption of the Wnt-beta-catenin pathway in UUO mice. （ポスター掲示，一般）
98.	2012/05/26	Raloxifene Ameliorates Proteinuria-Induced Inflammasome Activation and Tubular Injury. （ポスター掲示，一般）
99.	2012/05/25	Endothelial Dysfunction promotes the Transition from Compensatory Renal Hypertrophy to Kidney Injury after Unilateral Neophrectomy in Mice. （ポスター掲示）
100.	2012/05/25	Preservation of Endothelial GTP Cyclohydrolase I Activity and Improvement of Renal Nitric Oxide Availability Prevent the Development of Diabetic Nephropathy （ポスター掲示，一般）
101.	2011/11/12	Low-Dose Erythropoietin Increases Superoxide Production in Normal Rat Aorta and Endothelial Cells （ポスター掲示，一般）
102.	2011/11/12	Selective Estrogen Receptor Modulator Inhibits Fatty Acid-Induced Inflammasome Activation and Attenuates Proteinuria-Induced Tubular Injury in Mice （ポスター掲示，一般）
103.	2011/11/11	Implications of Oxidative Stress Derived from Endothelial NAD(P)H Oxdase in the Development of Diabetic Nephropathy （ポスター掲示，一般）
104.	2011/11/10	Mouse Renal Fibrosis after Unilateral Ureteral Obstruction Is Reduced by Klotho Protein Overexpression through Wnt Signaling Inhibition （ポスター掲示，一般）
105.	2011/11/10	Preservation of Endothelial GTP Cyclohydrolase I Activity by Metformin Prevent the Development of Diabetic Nephropathy （ポスター掲示，一般）
106.	2011/09/22	Endothelial NAD(P)H oxidase activation enhance urinary albumin excretion and progress renal dysfunction in mouse type 1 diabetic nephropathy. （ポスター掲示，一般）
107.	2011/09/22	Role of GTP cyclohydrolase-1 as a novel therapeutic target of diabetic nephropathy. （ポスター掲示，一般）
108.	2011/05/12	Effect of selective estrogen receptor modulator in renal proximal tubles. （ポスター掲示，一般）
109.	2011/04/11	Selective Estrogen Receptor Modulator Ameriorate Proteinuria Induced Tubular Damage by Reducing Oxidative Mitochondrial Stress. （ポスター掲示，一般）
110.	2011/04/10	Cyclic GMP Dependent Protein Kinase-Akt Pathway is Essential for Compensatory Renal Hypertrophy and Maintenance Renal Function After Unilateral Nephrectomy. （ポスター掲示，一般）
111.	2011/04/10	Over-Expression of Endothelial GTP Cyclohydrolase-ⅠAmeliorates Mouse　Diabetic Glomerulopathy. （ポスター掲示，一般）
112.	2010/11/20	Selective Estrogen Receptor Modulator Attenuates Alubumin-Induced Apoptosis in Renal Proximal Tubules through Inhibition ob Mitochondrial Stress （ポスター掲示，一般）
113.	2010/11/19	Nitric Oxide Induces Tubular Cell Hypertrophy Via Cyclic GMP-Dependedent Protein Kinase in Rat Compensatory Renal Hypertrophy （ポスター掲示，一般）
114.	2010/11/18	Over-Expression of GTP Cyclohydrolase-ⅠRetards Development of Albuminuria and Ameliorates Renal Injuries in Diabetes （ポスター掲示，一般）
115.	2010/06/27	Mechanisms of acute tacrolims-induced nephrotoxicity and the renoprotective effects of telmisartan （ポスター掲示，一般）
116.	2010/06/26	Calcium channel blokers azelnidipine but not amlodipine reduce glomerular damages in Dahl salt -sansitive rats by suppression of sympathetic nerve system （ポスター掲示，一般）
117.	2010/06/26	Establishment of new blood purification system in renal failure rats using a small dialyzer （ポスター掲示，一般）
118.	2010/06/26	Renal denervation reduces glomerular superoxide production and protects from gromerular injury in Dahl salt-sensitive rats （ポスター掲示，一般）
119.	2010/06/15	Renal denervation attenuates glomerular schrelosis by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats （ポスター掲示，一般）
120.	2010/04/17	ARB/CCB combination therapy suppressed oxidative stress compared with ARB/HCTZ combination therapy in glomeruli and aorta of metabolic syndrome model rats （ポスター掲示，一般）
121.	2010/04/17	Glomerular endothelial glycocalyx was decreases by reactive oxygen species in Zucker obese fatty rat （ポスター掲示，一般）
122.	2010/04/17	Klotho overexpression attenuates renal fibrosis after unilateral obstruction by Wnt signaling inhibition （口頭，特別講演・招待講演など）
123.	2010/04/16	Renal denervation protects from glomerular injyury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats （ポスター掲示，一般）
124.	2010/03/05	Deterioration of Glomerular Endothelial Glycocalyx Induced by Heparanase is Imvolved in Cardio-Renal Interaction （ポスター掲示，一般）
125.	2009/10/31	Renal Denervation Protects Renal Function by Suppressing NAD(P)H Oxidase Activity in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
126.	2009/10/30	Azelnidipine Prevents Renal Dysfunction by Suppression of Sympathetic Nerve System in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
127.	2009/10/30	Deterioration of Glomerular Endothelial Glycocalyx Induced by Oxidative Stress is Implicated in Altered Permeability of Macromolecules in Zucker Obese Fatty Rat （ポスター掲示，一般）
128.	2009/10/30	Increased Angiostatin Production by Nitric Oxide Reduction Induces Tubulointerstitial Damage in Rat Aging Kidney （ポスター掲示，一般）
129.	2009/10/29	Alpha-Klotho Attenuates Renal Fibrosis after Unilateral Ureteral Obstruction through Inhibition of Wnt Signaling （ポスター掲示，一般）
130.	2009/10/29	Comparison of the Renal and Vascular Protective Effects of Olmesartan/Azelnidipine with Olmesartan/Hydrochlorothiazide Combination Therapy in Metabolic Syndrome Model Rats （ポスター掲示，一般）
131.	2009/10/29	Development of Novel Blood Purification System in Rats （ポスター掲示，一般）
132.	2009/10/29	Overexpression of Klotho Protein Inhibits Uninephrectmy Induced Compensatory renal Hypertrophy by Suppressing Insulin Like Growth Factor-1 Signals （口頭，一般）
133.	2009/10/29	Renoprotective Effects of Azelnidipine by Improvements of renal Microcirculation in Angiotensin ll infusion Rat. （ポスター掲示，一般）
134.	2008/07	Relation between nitric oxide (NO) and NO-related substances in continuous ambulatory peritoneal dialysis （一般）
135.	2008/02/28	Effects of high-volume or high-flow continuous renal replacement therapy and PMX-DHP for patients with septic shock （ポスター掲示，一般）
136.	2008/02/27	Effect of High-Volume or High Flow Continuous Reanal Replacement Therapy and PMX-DHP for Patients with Septic Shock. （ポスター掲示，一般）
137.	2008/02/27	High-Flow Isovolemic Continuous Hemodialysis Improves 28-Day Mortality in Patients with Septic Shock. （ポスター掲示，一般）
138.	2007/11/22	Are Dietary Supplements Safe and Efficacy in Peritoneal Dyalysis? （ポスター掲示）
139.	2007/11/22	Direct Measurement of Nitric Oxide and Tetrahydrobiopterin Levels in Peritoneal Dialysate （ポスター掲示，一般）
140.	2007/11/22	Measures to Maintain Appropriate Level of Serum Phosphorus （ポスター掲示，一般）
141.	2007/10/31	Compensatory Kidney Growth after Rat Nephrectomy Requier Superoxide Via NADPH Oxidase （ポスター掲示，一般）
142.	2007/10/31	Direct Measurement of Nitric Oxide Levels in Peritoneal Dialysate. （ポスター掲示，一般）
143.	2007/10/31	In VivoVisualization of Glomerular Hyperfiltration and Microcircuration in STZ-Induced Diabetic Rats. （ポスター掲示，一般）
144.	2007/04/26	Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis （口頭，シンポジウム・ワークショップパネル（その他））
145.	2006/11/14	Possible Mechanism in Improvement of Progressive Renal Injuries in Klotho Over-Expressing ICGN Mice （ポスター掲示，一般）
146.	2006/11/14	Suppression of Oxidative Stress by Combination Therapy with a Statin and an ACE Inhibitor STZ-Induced Diabetic Rat. （ポスター掲示，一般）
147.	2006/11/14	Therapeutic Effect Pitavastatin on Renal Injury Induced by Hypertension （ポスター掲示，一般）
148.	2006/10/20	NAD(P)H oxidase and Uncoupled Nitric Oxide Synthase are Major Sources of Superoxide in Hypertensive and Diabetic Rat Kidney （ポスター掲示，一般）
149.	2006/10/15	Direct Method to Detect Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Kidney of Hypertensive Rats
150.	2006/10/15	Hops-derived Isohumulones Ameliorate Renal Injury through Anti-oxidative Effect in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
151.	2006/10/15	Relation of Endothelial Dysfunction in Rheumatoid Arthritis to Adiponection Level
152.	2006/10/15	Role of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Hypertrophy in Kidney after Uninephrectomy
153.	2006/10/15	Therapeutic Effect of Pitavastatin on Renal Injury Induced by Hypertension
154.	2006/10	Sarpogrelate Hydrochloride Inhibits Reactive Oxygen Species (ROS) Production in Diabetic Nephropathy （ポスター掲示）
155.	2006/08/25	A Study of Tailored Nutrition Support for Peritoneal Dialysis Patients （ポスター掲示）
156.	2006/08/25	Direct Measurement of Effluent Nitric Oxide Levels in CAPD Patients （ポスター掲示）
157.	2006/08/25	The Effects of Calcium Intake and Bone Assessment Index in Continuous Ambulatory Peritoneal Dialysis(CAPD) Patients （ポスター掲示）
158.	2005/11/08	Implication of Senescence Associated Klotho Gene in the Pathogenesis of Progressive Renal Injuries. （口頭，一般）
159.	2005/11/08	Mitochondrial Dysfunction Impairs Up-Regulation of Vascular Endothelial Growth Factor Expression in the Aging Kidney. （ポスター掲示，一般）
160.	2005/11/08	Role of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Hypertrophy in the Kidney after Uninephrectomy. （ポスター掲示，一般）
161.	2004/10/27	Abnormalities in Renal Autoregulation Due to Imbalance Reactive Oxygen Species and Nitric Oxide. （ポスター掲示，一般）
162.	2004/10/27	Losartan Improves the Imbalance between Nitric Oxide and Reactive Oxygen Species in the Diabetic Nephropathy （ポスター掲示，一般）
163.	2004/10/27	The Role of Abnormal Iron Metabolism in the Development of Oxidative Peritoneal Injury （ポスター掲示，一般）
164.	2003/11/12	A Long Acting Calcium Channel Blocker, Azelnidipine, Ameliorates Angiotensin II Induced Renal Damage in Rats. （ポスター掲示，一般）
165.	2003/11/12	Calcium Channel Blocker and Angiotensin Redceptor Blocker Improve Tubulointerstitial Hypoxia and Prevent Progress of Tubular Damage in the Dahl Salt Sensitive rat Kidney （ポスター掲示，一般）
166.	2003/11/12	Imbalance of Nitric Oxide and Reactive Oxygen species Contributes to the Progression of Renal Damage in Rat 5/6 Remmnant Model （ポスター掲示，一般）
167.	2003/11/12	In situ Detection of Nitric Oxide in the Rat Kidney Using the Fluorescent Dye, Diaminorhodamine （ポスター掲示，一般）
168.	2003/11/12	NAD(P)H Oxidase and Uncoupled Nitric Oxide Synthase Are Major Sources of Superoxide in the Rat Experimental Diabetic Nephropathy （ポスター掲示，一般）
169.	2003/11/12	Progranulin (PC-Cell-Derived Growth Factor) Expression in the Kidney of Various Rat Renal Disease Models （ポスター掲示，一般）
170.	2003/11/12	The Implications of NO and ROS Their Interaction in the Pathogenesis of Peritoneal Injury （ポスター掲示，一般）
171.	2003/06/08	continuous hemodialysis improves the mortality of critical patients with acute renal failure in comparison with continuous hemofiltration
172.	2002/11/02	Novel Free Radical Scavenger, MCI-186,Protects Cisplatin-Induced Acute Renal Damage In Vitro and In Vivo. （ポスター掲示，一般）
173.	2002/11/01	Impaird Angiogenesis in the Development on Interstitial Fibrosis in the Progressive Renal Diseases. （ポスター掲示，一般）
174.	2002/11/01	the Role of Angiotensin II in yhe Genoeration of Oxidative Stress in Progressive Renal Diseases:Effects of ACEI and ARB. （ポスター掲示，一般）
Display 5 items
Display all(174)